The report titled “Umbilical Cord Blood Banking Market- Growth, Future Prospects, and Competitive Analysis, 2017 – 2025” offers strategic insights into the overall umbilical cord blood banking market along with the market size and estimates for the duration 2015 to 2025. The said research study cover in-depth analysis of multiple market segments based on type of storage, application, and different geographies. Umbilical cord and placental blood are rich in stem cells that can be used to treat diseases such as leukemia, lymphoma, myeloma, aplastic anemia and certain immunologic and metabolic disorders. Cord blood is considered as the safest option compared to other stem cell sources due to its non-invasiveness and minimal risk to mother and child.

For the purpose of this study, the global umbilical cord blood banking market is segmented on the basis of storage type into private cord blood banks and public cord blood banks. Market size estimates and forecast for these segments for the period 2015 to 2025 are provided in terms of USD Mn along with the respective compounded annual growth rates (CAGRs) for the period 2017 to 2025, considering 2016 as the base year.

The global umbilical cord blood banking market is also segmented on the basis of type of applications such as cancer, blood disorders, metabolic disorders, immune disorders, and osteopetrosis. Market size estimates and forecast for these segments for the period 2015 to 2025 are provided in terms of USD Mn along with the respective compounded annual growth rates (CAGRs) for the period 2017 to 2025, considering 2016 as the base year.

The geographical segmentation of umbilical cord blood banking market comprised regions such as North America, Europe, Asia-Pacific, Latin America & Middle East and Africa. Each geographical region is further split to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, Brazil, Mexico, Saudi Arabia, South Africa, and other countries. Market size and forecast for these segments during 2015 to 2025 and their CAGRs for the period 2017 to 2025 are provided in this report.

The umbilical cord blood banking market is observed as the most diversified and competitive market comprising large number of players.  The market is dominated by several players, depending on their major competencies. The key players in this market are CBR Systems, Inc., ViaCord Inc., China Cord Blood Corporation, Cord Blood America, Inc., Cryo-Cell International, Inc., Cryo-Save AG, Cordlife Group Ltd., Vita 34 AG, LifeCell, and StemCyte Inc. among others.

In year 2016, private cord blood banks was observed as the largest segment due to key driving factors such as complete ownership rights secured by the donor, widespread collection sites, and high assurance related with the security and storage facilities. On the other hand, public cord blood banks collect & store the cord blood derived stem cells and do not process & store cord tissue stem cells. According to Cryocell International, in case of public cord blood banks it has been observed that approximately 70% of cord blood donated to public banks is discarded for not meeting process and storage criteria. Thus, demand and preference for private banks is expected increase in the near future.

Rising prevalence of cancer, rising demand for stem cell therapy in cancer treatment, developing research activities in the field of cancer treatment and increasing awareness associated with early cancer diagnosis are the key factors driving the overall cord blood banking market. In year 2016, cancer was observed as the largest application segment in the global umbilical cord blood banking market. According to Cancer Research UK, in 2012, an estimated 14.1 million new cases of cancer occurred worldwide and more than 4 in ten cancers occurring worldwide are in countries at a low or medium level of Human Development Index (HDI). Furthermore, the four most common cancers occurring worldwide are lung, female breast, bowel and prostate cancer. Thus, the demand for safe and effective cancer therapies are in demand and most of the hematological cancers are being treated with stem cell therapy.

In base year 2016, North America accounted for the largest share in global umbilical cord blood banking market due to key driving factors such as rising demand for cord blood in stem cell research, increasing awareness related to benefits of cord blood banking, developed research and healthcare infrastructure, and incessant development in the field of storage and application of stem cells extracted from cod blood. During the forecast period 2017- 2025, Asia Pacific was observed as the most potential market due to rising public awareness related to the advantages of cord blood banking, comprises many untapped markets, and increasing government support and initiatives. The potential of cord blood stem cells for regenerative therapies has encouraged the number of cord blood banks in the Asia. However, apart from countries like Japan and Singapore, other countries such as China, Vietnam, South Korea, Malaysia, India and Taiwan also claim about their own cord blood banks.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Umbilical Cord Blood Banking market are as follows:

• Research and development budgets of manufacturers and government spending
• Revenues of key companies in the market segment
• Number of end users and consumption volume, price and value.
• Geographical revenues generate by countries considered in the report
• Micro and macro environment factors that are currently influencing the Umbilical Cord Blood Banking market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Umbilical Cord Blood Banking market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2032.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Umbilical Cord Blood Banking market?
• Which is the largest regional market for Umbilical Cord Blood Banking market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Umbilical Cord Blood Banking market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Umbilical Cord Blood Banking market worldwide?